Clik here to view.
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Kyowa Hakko Kirin (Tokyo:4151), announced today that they have entered into an agreement to explore the therapeutic potential of the combination of...
View ArticleClik here to view.
Bionic Vision Australia Successfully Completes Clinical Trial of Implant in...
MELBOURNE, Australia Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today...
View ArticleClik here to view.
BioJapan 2014 World Business Forum 出展企業プロフィール
横浜 （ビジネスワイヤ） – BioJapan 2014 World Business Forumが、2014年10月15日（水）～ 17（金）に、パシフィコ横浜（横浜市西区）で開催されます。 ビジネスワイヤはBioJapan...
View ArticleClik here to view.
BioJapan 2014 World Business Forum Exhibitor Profiles
YOKOHAMA, Japan BioJapan 2014 World Business Forum takes place October 15 – 17 at the PACIFICO YOKOHAMA in Yokohama, Japan. Business Wire is the official media partner for the BioJapan 2014....
View ArticleClik here to view.
GE Healthcare Study: Most People Unaware that Women with High Breast Density...
CHALFONT ST GILES, England Three out of four people are not aware that dense breast tissue increases a woman’s risk of developing breast cancer, 1, 2 according to a new global study from GE...
View ArticleClik here to view.
【 BioJapan 】 － アジア最大級のバイオ総合展 －世界のバイオ企業が日本に熱視線！ビッグファーマ・ベンチャー・アカデミアが創る新バイオビジネス
東京 （ビジネスワイヤ） — 来る2014年10月15日（水）～17日（金）の3日間、パシフィコ横浜の展示ホールC・Dとアネックスホール全館においてBioJapan 2014 – World Business Forum – を開催します。 BioJapan...
View ArticleClik here to view.
EDPバイオテックが大腸がん早期発見に資するインビトロ診断ツールColoMarkerのCEマーク認証取得と欧州での商業化計画を発表
米テネシー州ノックスビル （ビジネスワイヤ） —...
View ArticleClik here to view.
DNA Sequencing HPV Testing and Pap Smears Necessary for Optimum Patient Care,...
MILFORD, Conn. Sin Hang Lee, M.D., a Milford (Conn.) Hospital pathologist and lead author of “From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice,” a...
View ArticleClik here to view.
Stryker Corporation Completes Acquisition of French, German and Asia Pacific...
MORRISVILLE, Pa. Small Bone Innovations, Inc. (SBi) today announced that on Sept. 30, 2014 the sale of the assets of its international business, including the assets of its French, German and Asia...
View ArticleClik here to view.
Perosphere and Daiichi Sankyo Enter into a Clinical Trial Collaboration...
DANBURY, Conn. Perosphere Inc. announced today that it has entered into a third clinical trial collaboration agreement with Daiichi Sankyo, Inc. to study PER977, Perosphere’s investigational...
View ArticleClik here to view.
EOS imaging Expands Market Presence in South East Asian with First Vietnam...
PARIS EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announces the Company’s continued growth in the South East Asian market with...
View ArticleClik here to view.
TowerJazz and Korea Electrotechnology Research Institute (KERI) Collaborate...
MIGDAL HAEMEK, Israel & CHANGWON, South Korea TowerJazz (NASDAQ: TSEM) (TASE: TSEM), the global specialty foundry leader, and the Korea Electrotechnology Research Institute (KERI), a non-profit...
View ArticleClik here to view.
Nihon Kohden Supports Epilepsy Research Funding
IRVINE, Calif. For the sixth consecutive year, Nihon Kohden America Inc., a market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation, has auctioned off one of...
View ArticleClik here to view.
Seattle Genetics与武田发布 ADCETRIS® (Brentuximab...
华盛顿州博瑟尔和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502)今天宣布，自体干细胞移植(ASCT)后立即接受ADCETRIS (brentuximab...
View ArticleClik here to view.
EDP Biotech宣布， ColoMarker已获得CE标记，获准用于结肠癌早期检测中的体外辅助诊断，计划在欧洲商业化
田纳西州诺克斯维尔 (美国商业资讯) — EDP Biotech Corporation（以下简称“EDP”或 “公司”）是一家全球性的体外诊断创新公司，采用ELISA技术进行挽救生命的、易用的癌症诊断检测，该公司宣布，其用于结肠癌早期检测的辅助诊断产品ColoMarker®已获得CE标记。这是该独特产品走向商业化的关键步骤，该产品将率先在欧洲经济区(EEA)所属30个成员国上市。 EDP...
View ArticleClik here to view.
PharmaEngine, Nanobiotix Enter Global Pivotal Trial of PEP503 (NBTXR3) in...
TAIPEI, Taiwan PharmaEngine Inc. (TWO: 4162), a biopharmaceutical company developing new cancer treatments, and Nanobiotix S.A. (Euronext: NANO), a clinical-stage nanomedicine company pioneering in...
View ArticleClik here to view.
Manhattan Scientifics’ Unparalleled Cancer Measurement Technology Featured in...
ALBUQUERQUE, N.M. Senior Scientific LLC, a subsidiary of Manhattan Scientifics, Inc. (OTCQB: MHTX), is currently collaborating with The University of Texas MD Anderson Cancer Center (MDACC) to...
View ArticleClik here to view.
シアトル・ジェネティクスと武田薬品が移植後ホジキンリンパ腫治療の地固め療法としてのアドセトリス（ブレンツキシマブ・ベドチン）の第3相AETHERA臨床試験...
米ワシントン州ボセル & 大阪 （ビジネスワイヤ） — シアトル・ジェネティクス（Nasdaq:...
View ArticleClik here to view.
Gynesonics Named to FierceMedicalDevices ’2014 Fierce 15′
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has been named by...
View ArticleClik here to view.
FDA Approves VELCADE® (bortezomib) for Injection for Previously Untreated...
CAMBRIDGE, Mass. Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the U.S. Food and Drug Administration (FDA)...
View Article